Serial Number
98468761
Owner
NOVOTECH HOLDINGS USA LLCAttorney
Matthew P. Hintz, Esq.First Use Date
Mar 14, 2024
Filing Date
Mar 26, 2024
NT NOVOTECH BIOTECH'S PARTNER AT EVERY PHASE Trademark
Serial Number: 98468761 • Registration: 7782910
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
One Lowenstein Drive
Roseland, NJ 07068
United States
Trademark Details
Filing Date
March 26, 2024
Registration Date
May 6, 2025
First Use Anywhere
March 14, 2024
First Use in Commerce
March 14, 2024
Published for Opposition
March 18, 2025
Goods & Services
Business advisory and consultancy services relating to product development; business advisory and consultancy services relating to regulatory compliance; business research services; market research services; all of the aforementioned services being in the fields of pharmaceuticals, biotechnology and other related industries
Scientific research in the nature of conducting clinical trials for others; conducting and managing clinical trials, including clinical trials for pharmaceuticals, biotechnology and other related industries; providing information about the results of clinical trials, including clinical trials for pharmaceuticals and biotechnology; scientific research; medical research, namely, scientific research for medical purposes; preparation of statistics for scientific research; preparation of biostatistics for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality control for others; preparation of reports and applications to regulators relating to aspects of clinical trials; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols